3-Aminopyridine-2-Carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors
This study has been completed.
Sponsor:
Vion Pharmaceuticals
Information provided by:
National Cancer Institute (NCI)
ClinicalTrials.gov Identifier:
NCT00004213
First received: January 28, 2000
Last updated: July 23, 2008
Last verified: December 2007
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Study Status: | This study has been completed. |
|---|---|
| Estimated Study Completion Date: | No date given |
| Estimated Primary Completion Date: | No date given |